Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

The cutoff BP values for hypertension should not be lowered in China

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127–e248.

    Article  Google Scholar 

  2. SPRINT Research Group, Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, et al. Final report of a trial of intensive versus standard blood-pressure control. N. Engl J Med. 2021;384:1921–30.

    Article  Google Scholar 

  3. American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022[J]. Diabetes Care. 2022;45:S144–74.

    Article  Google Scholar 

  4. Kario K, Mogi M, Hoshide S. Latest hypertension research to inform clinical practice in Asia. Hypertens Res. 2022;45:555–72.

    Article  Google Scholar 

  5. Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N. Engl J Med. 2021;385:1268–79.

    Article  CAS  Google Scholar 

  6. Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625–36.

    Article  Google Scholar 

  7. Rakugi H. Step for breaking free from clinical inertia. Hypertens Res. 2022;45:5–7.

    Article  Google Scholar 

  8. Zhang WL, Cai J. STEP to blood pressure management of elderly hypertension: evidence from Asia. Hypertens Res. 2022;45:576–82.

    Article  Google Scholar 

  9. Ohkubo T. Utility of the “Strategy of Blood Pressure Intervention in Elderly Hypertensive Patients” for home blood pressure management in a real-world setting. Hypertens Res. 2022;45:8–10.

    Article  Google Scholar 

  10. Kario K, Sakima A, Ohya Y. STEP to estimate cardiovascular events by home blood pressure in the era of digital hypertension. Hypertens Res. 2022;45:11–14.

    Article  Google Scholar 

  11. Jiao Y, Sun Z, Xie Y, Zheng J, Li Z, Guo X, et al. Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them. BMC Cardiovasc Disord. 2020;20:237.

    Article  Google Scholar 

  12. Yang C, Wang J, Gao B, Zhang Y, Wang F, Zhang L, et al. Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Sci Bull. 2018;63:488–93.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi-Fang Guo.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, RY., Guo, YF. The cutoff BP values for hypertension should not be lowered in China. Hypertens Res 45, 1526–1527 (2022). https://doi.org/10.1038/s41440-022-00969-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-022-00969-2

Search

Quick links